Analysts expect ArriVent BioPharma, Inc. to report revenue of 0.00 for Q2 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q1 26, came in at 0.00.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.81 M | 8.76 M | 8.78 M | 8.05 M | 36.28 M | |||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.23 M | 7.48 M | 7.85 M | 7.44 M | 31.33 M | |||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.02 M | 8.12 M | 8.31 M | 7.75 M | 33.80 M |
Analysts expect ArriVent BioPharma, Inc. to report earnings per share of -0.97 for Q2 26, against a range of -1.05 to -0.89. The most recent reported quarter, Q1 26, came in at -0.96, a 12.9% miss against the -0.85 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.65 | -0.61 | -0.60 | -1.90 | -0.90 | -0.83 | -0.84 | -0.96 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -0.62 | -0.96 | -0.58 | -0.59 | -0.69 | -0.80 | -0.83 | -0.82 | -0.89 | -0.94 | -1.10 | -0.87 | -0.67 | -0.86 | -1.01 | -0.53 | |||||||||||
| Low Estimate | -0.74 | -1.12 | -0.66 | -0.65 | -0.81 | -0.88 | -0.97 | -0.88 | -1.05 | -1.00 | -1.20 | -0.97 | -0.79 | -0.96 | -1.11 | -0.61 | |||||||||||
| Consensus Estimate | -0.68 | -1.04 | -0.62 | -0.62 | -0.75 | -0.84 | -0.90 | -0.85 | -0.97 | -0.97 | -1.15 | -0.92 | -0.73 | -0.91 | -1.06 | -0.57 |